世界の血液スクリーニング市場:技術別(核酸増幅、(リアルタイムPCR)、ELISA(化学発光免疫測定法)、ラピッドテスト、ウエスタンブロット)、製品別(機器、試薬&キット、ソフトウェア)、エンドユーザー別(血液銀行、病院)...市場調査レポートについてご紹介

【英文タイトル】Blood Screening Market by Technology (Nucleic Acid Amplification, (Real Time PCR), ELISA (Chemiluminescence Immunoassay), Rapid Test, Western Blot), Product (Instrument, Reagent & Kits, Software) & End User (Blood Bank, Hospital) - Global Forecast to 2024

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Introduction (Page No. – 20)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. – 23)
2.1 Research Data
2.2 Research Design
2.3 Secondary Data
2.3.1 Secondary Sources
2.4 Primary Data
2.4.1 Key Data From Primary Sources
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach
2.5.2 Top-Down Approach
2.5.3 Growth Forecast
2.6 Market Breakdown and Data Triangulation
2.7 Assumptions for the Study
3 Executive Summary (Page No. – 30)
4 Premium Insights (Page No. – 33)
4.1 Blood Screening Market Overview
4.2 Asia Pacific: Blood Screening Market Share, By End User & Country (2018)
4.3 Blood Screening Market, By Product & Service, 2019 vs. 2024 (USD Billion)
4.4 Geographical Snapshot of the Blood Screening Market
5 Market Overview (Page No. – 36)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Demand for Donated Blood and Rising Number of Blood Donations
5.2.1.2 Rising Prevalence of Infectious Diseases and Emergence of Newer Pathogens
5.2.2 Opportunities
5.2.2.1 Technological Advancements
5.2.2.2 Emerging Economies
5.2.3 Challenges
5.2.3.1 Need for Reducing Blood Screening Prices
6 Blood Screening Market, By Product & Service (Page No. – 41)
6.1 Introduction
6.2 Reagents & Kits
6.2.1 NAT Reagents & Kits
6.2.1.1 High Sensitivity and Rising Use of NAT are Boosting Demand for Related Reagents and Kits
6.2.1.2 Enzymes & Polymerases
6.2.1.3 Standards & Controls
6.2.1.4 Probes & Primers
6.2.1.5 Buffers, Nucleotides, & Solutions
6.2.1.6 Labeling & Detection Reagents
6.2.2 Elisa Reagents & Kits
6.2.2.1 Ease of Use and Cost-Effectiveness of Elisa Reagents & Kits Will Drive Market Growth
6.2.2.2 Immunosorbents
6.2.2.3 Controls
6.2.2.4 Conjugates
6.2.2.5 Substrates
6.2.2.6 Sample Diluents & Wash Solutions
6.2.3 Other Reagents & Kits
6.2.3.1 Increasing Use of Western Blot Tests and Rapid Tests Will Drive the Growth of This Market Segment
6.3 Instruments
6.3.1 Rental Purchase
6.3.1.1 Convenience and Cost-Effectiveness of Renting Instruments has Resulted in Greater End-User Preference
6.3.2 Outright Purchase
6.3.2.1 Availability of Government Support Will Increase the Outright Purchase of Instruments
6.4 Software & Services
6.4.1 Increasing Adoption of Instruments Will Drive the Demand for Related Software and Services
7 Blood Screening Market, By Technology (Page No. – 51)
7.1 Introduction
7.2 Nucleic Acid Testing
7.2.1 Transcription-Mediated Amplification
7.2.1.1 High Sensitivity of These Assays to Support Market Growth
7.2.2 Real-Time Polymerase Chain Reaction
7.2.2.1 Real-Time PCR Procedures Provide More Accurate and Effective Results as Compared to Conventional PCR
7.3 Enzyme-Linked Immunosorbent Assay
7.3.1 Chemiluminescence Immunoassay
7.3.1.1 Clia is Ultrasensitive, Automated, and A Good Alternative to Conventional Methodologies
7.3.2 Fluorescent Immunoassay
7.3.2.1 Rising Demand for Safer and Stable Reagents and the Development of Novel Markers to Support the Growth of This Market Segment
7.3.3 Colorimetric Immunoassays
7.3.3.1 CI Offers Low Sensitivity as It Uses Vulnerable/Limited Signal Amplification Strategies
7.4 Rapid Tests
7.4.1 Rising Awareness About Rapid Tests in Emerging Countries to Drive Market Growth
7.5 Western Blot Assay
7.5.1 Growing Prevalence of TTIS in Developing Countries has Resulted in the Increased Demand for Western Blot Assays
7.6 Next-Generation Sequencing
7.6.1 Ngs is an Emerging Technology in the Blood Screening Market
8 Blood Screening Market, By End User (Page No. – 62)
8.1 Introduction
8.2 Blood Banks
8.2.1 Blood Banks Hold the Largest Share of the Blood Screening Market
8.3 Hospitals
8.3.1 Increasing Number of Surgical Procedures Will Drive the Growth of the Hospitals Segment
9 Blood Screening Market, By Region (Page No. – 66)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 The US Dominates the Global Blood Screening Market
9.2.2 Canada
9.2.2.1 Growing Volume of Surgical Procedures Performed and High Burden of Cancer to Support Market Growth
9.3 Europe
9.3.1 Germany
9.3.1.1 Germany is the Largest Market for Blood Screening Technologies in Europe
9.3.2 France
9.3.2.1 Increasing Prevalence of Hiv to Support Market Growth
9.3.3 UK
9.3.3.1 Government Support to Prevent Transmission of Hiv and Other Infections Will Drive Market Growth
9.3.4 Italy
9.3.4.1 Italy is Witnessing an Increase in the Number of Blood Donors
9.3.5 Spain
9.3.5.1 Increasing Adoption of NAT Technology Will Support Market Growth
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.1.1 China has A High Prevalence of Infectious Diseases
9.4.2 Japan
9.4.2.1 Japan has Witnessed an Increase in the Adoption of Advanced Blood Screening Technologies
9.4.3 India
9.4.3.1 Increasing Number of Road Accidents Will Support Market Growth
9.4.4 Australia
9.4.4.1 Rising Number of Blood Donations Will Propel Market Growth
9.4.5 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.1.1 Increasing Incidence of Cancer Will Support the Growth of This Market
9.5.2 Rest of Latin America
9.6 Middle East & Africa
9.6.1 Rising Prevalence of Infectious Diseases Will Drive Market Growth in the Region
10 Competitive Landscape (Page No. – 114)
10.1 Overview
10.2 Market Share Analysis, 2018
10.2.1 Market Share Analysis for NAT Blood Screening, 2018
10.2.2 Market Share Analysis for Total Blood Screening, 2018
10.3 Competitive Scenario
10.3.1 Partnerships, Agreements, and Collaborations (2017–2019)
10.3.2 Product Launches (2017–2019)
10.3.3 Expansions (2017–2019)
10.3.4 Acquisitions (2017–2019)
10.4 Competitive Leadership Mapping (2019)
10.4.1 Vendor Inclusion Criteria
10.4.2 Visionary Leaders
10.4.3 Innovators
10.4.4 Dynamic Differentiators
10.4.5 Emerging Companies
11 Company Profiles (Page No. – 122)
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 Grifols
11.2 F. Hoffmann-La Roche
11.3 Abbott Laboratories
11.4 Biomérieux
11.5 Bio-Rad Laboratories
11.6 Becton, Dickson and Company
11.7 Danaher Corporation
11.8 Ortho Clinical Diagnostics
11.9 Siemens Healthineers
11.10 Thermo Fisher Scientific
11.11 Diasorin
11.12 GE Healthcare
11.13 Merck KGaA
11.14 Perkinelmer
11.15 Bio-Techne
11.16 GFE
11.17 Trinity Biotech
11.18 J. Mitra Diagnostics Pvt. Ltd.
*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.
12 Appendix (Page No. – 159)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details


【レポート販売概要】

■ タイトル:世界の血液スクリーニング市場:技術別(核酸増幅、(リアルタイムPCR)、ELISA(化学発光免疫測定法)、ラピッドテスト、ウエスタンブロット)、製品別(機器、試薬&キット、ソフトウェア)、エンドユーザー別(血液銀行、病院)
■ 英文:Blood Screening Market by Technology (Nucleic Acid Amplification, (Real Time PCR), ELISA (Chemiluminescence Immunoassay), Rapid Test, Western Blot), Product (Instrument, Reagent & Kits, Software) & End User (Blood Bank, Hospital) - Global Forecast to 2024
■ 発行日:2019年12月23日
■ 調査会社:MarketsandMarkets
■ 商品コード:MD 3687
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。